Transcatheter mitral valve repair with the PASCAL device showed high rates of survival and freedom from heart failure rehospitalization at 2 years in the single-arm, safety and efficacy CLASP study.

SAN FRANCISCO -- The Pascal device remained noninferior to MitraClip for prohibitive surgical risk patients with significant symptomatic degenerative mitral regurgitation (DMR) in full results from ...

SAN FRANCISCO, CA—For patients with symptomatic degenerative mitral regurgitation (DMR) and a prohibitive surgical risk, transcatheter edge-to-edge repair (TEER) with either of two approved devices ...

SAN FRANCISCO, Oct. 26, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced one-year results from CLASP IID, the first randomized controlled trial that directly compares two ...

Please provide your email address to receive an email when new articles are posted on . Patients with severe degenerative mitral regurgitation saw sustained benefits with a novel transcatheter edge-to ...

In another news, a new device Tendyne transcatheter mitral valve replacement (TVMR) system has been approved by the US Food and Drug Administration (FDA) for the treatment for patients who are ...

During what has been a rollercoaster-like pattern for more than a decade, market expectations for transcatheter mitral valve replacement (TMVR) devices are continuing to follow an upward trajectory in ...

NEW YORK CITY -- Real-world operators have been leaving patients with acceptable but still less-than-optimal results after transcatheter mitral edge-to-edge repair (M-TEER), with some suggesting ...

The FDA delivered a blow to Abbott Monday when a staff review ahead of a regulatory panel recommended that the agency r eject the company's application for approval for its minimially invasive mitral ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...